Improving transplantation programs and patient care.
Organ transplantation is the preferred mode of replacement therapy. Currently acceptable 5-year posttransplantation survival rates are 85% for renal grafts, 70% for liver, and 65% for heart. Organ donation, however, remains a significant factor in organ transplantation, as humans are the only possible donors and the numbers of patients on waiting lists remain high. Several factors affect organ transplantation in countries in the Middle East Society for Organ Transplantation (MESOT) region, including inadequate preventive medicine, differing health infrastructures, poor awareness within the medical community and lay public regarding the importance of organ donation and transplantation, a high level of ethnicity, and poor government support of organ transplantation. Moreover, there is lack of team spirit among transplant physicians, a lack of coordination between groups that manage organ procurement and the transplant centers, and a lack of effective health insurance coverage for many persons. Three models of organ donation and transplantation exist in the MESOT region-the Saudi, Iranian, and Pakistani models. Living-organ donation, the most widely practiced form of donation in countries in the MESOT region, includes kidney and partial liver. Cadaveric organ donation has significant potential in the MESOT region. However, numerous obstacles must be overcome in MESOT countries. Resolution of these obstacles will require continuous work on many fronts. Experiences from all sources must be incorporated into new and improved models that can overcome current inadequacies. Solutions will require continued focus within the medical community, steady support from the lay public and religious institutions, as well as governmental assistance.
Shaheen
F A M
FA
Saudi Center for Organ Transplantation, Riyadh, Saudi Arabia. famshaheen@yahoo.com
Souqiyyeh
M Z
MZ
D006801:Humans; D016030:Kidney Transplantation / Q000331:legislation & jurisprudence / Q000401:mortality / Q000592:standards*; D008877:Middle East; D016377:Organ Transplantation / Q000592:standards*; D017582:Renal Replacement Therapy / Q000401:mortality; D012529:Saudi Arabia; D012955:Societies, Medical; D016019:Survival Analysis; D014019:Tissue Donors / Q000600:supply & distribution